New study battles superbugs with powerful drug cocktails
NCT ID NCT07524920
First seen May 05, 2026 · Last updated May 07, 2026 · Updated 1 time
Summary
This study compares two different antibiotic combinations to see which works better at eliminating multi-drug resistant (MDR) bacteria in adults. About 60 participants aged 18-85 with confirmed MDR infections will receive either meropenem plus colistin or imipenem/cilastatin plus tigecycline. Researchers will track lab results, symptoms, and side effects to determine the safer and more effective option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDR BACTERIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
El-Demerdash hospital
Cairo, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.